arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

PLUS THERAPEUTICS, INC.

PSTV
$3.87 0.00 (0.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

PLUS THERAPEUTICS, INC. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $25.7M
Dividend Yield
Revenue Growth -2.9%
Op. Margin None
ROIC -47.0%
FCF / Share $-1.06
Trailing P/E
Price / Book 2.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Jul 31, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.03M
↓ -2.9%
Net Income Profit after all expenses
$-6.95M
↑ +60.1%
Operating Margin Operating profit as % of sales
-420.0%
↓ -30.9% 0th
FCF / Share Free cash flow per share
$-1.06
↑ +90.0%
Long-Term Debt Long-term obligations
$3.79M
↓ -7.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Cash Quality
62

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters